| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |